I lead the team responsible for GL Accounting, Accounts Payable, and Technical Accounting at Webflow. My team of 5 executes month-end close for all GL and technical accounting matters, owns all payment processes (including T&E / corporate cards) and delivers the results to our executive team, investors, and Board of Directors. We collaborate closely with finance on budget-to-actuals reporting. We are focused on scaling our operations while delivering reliable results for our stakeholders and auditors. We strive to create efficiencies through process improvement and automation. Our tech stack (past and present) includes Netsuite, Zip, Bill.com, Ramp, Brex, Abacus/Emburse, TripActions, Pilot, Stripe, and Workday.

Senior Manager of Platform Accounting on the Content Accounting team.

• Head of finance and accounting of all three entities in Africa, responsible for all statutory filingrequirements, tax compliance, revenue, accounts payable, payroll, and month-end close• Developed monthly budget forecast for all operations in Africa and reporting process for Actuals• Implemented comprehensive compliance program to include KYC, investigations, anti-money laundering controls, policies, training, and monitoring• Managed four direct reports on the finance team and one on the compliance team• Responsible for assessing bad debt and ensuring revenue and assets are reported in accordancewith GAAP, including ASC 606 adoption in 2019• Built process for fixed asset capitalization• Reviewed and approved all international trade and operations payments• Wrote the company’s first policies on accounting for bad debt, credit memos, accounts payable,expense reporting, fixed assets, and KYC.

Finance Manager in Partnering Finance-Responsible for forecasting and reporting ~$1.5 billion in annual royalty income and ~$500 million in annual royalty expense; this includes monthly outlooks, budget setting, and the long-term business planning-Perform all month-end close activities for Genentech royalties and R&D cost sharing between Genentech and Roche- Provide variance commentary to senior leadership, corporate accounting, and Roche headquarters

Finance lead responsible for the planning and reporting of approximately $100M in annual sales and $7M in marketing spend for the U.S. Institutional Business. This business is comprised of four separate sales channels including government, hospital, acute care, and clinical trials. As the primary finance lead for this sales organization, I provided all financial analyses requested by the general manager, marketing director, product managers, sales directors, and field sales team.Additionally, I was responsible for managing all capital expenditures for the entire U.S. Commercial organization during a time of significant investment leading up to the U.S. launch of Libre Pro and Libre. This required working closely with the commercial and IT functions to accurately forecast, request capital expenditures, report Actual spend, track project progression, explain any variances to budget, and ensure audit readiness for over $100 million in capital investment.

Finance & Compliance Auditor for Abbott Laboratories Corporate Audit•Supervised and performed financial and operational audits of 14 Abbott international and domestic businesses to assess the accuracy of financial statements and adequacy of internal controls in compliance with US GAAP and corporate policies •Conducted sales and marketing compliance audits of 10 domestic and international businesses to ensure compliance with corporate policies, Foreign Corrupt Practices Act (FCPA), and local anti-corruption laws and regulations •Responsible for audit planning and execution, including risk assessment, defining audit scope, resource allocation, budgeting, weekly meetings with senior management, and report issuance•Advised business unit management on accounting best practices and process improvements

Corporate Accountant/Financial AnalystRotation 1: The Clara Abbott Foundation Helped support and manage investment portfolio to fund operations, maintained weekly cash flow reports, prepared the monthly financials and completed monthly balance sheet reconciliations. Projects included conducting an expense audit and developing a database in the accounting system of historical client information. Rotation 2: Abbott International Latin America Headquarters Supported commercial operations of Latin America affiliates. Primarily focused on forecasting pharmaceutical sales in Latin America for the week, month, and year. Also participate in month-end close for actual sales, as well as consolidation of affiliates for various planning cycles.Rotation 3: Abbott Diabetes Care, Cost Accounting, United Kingdom OperationsSupported manufacturing operations in UK plant by forecasting weekly Material Usage and Direct Labor variances. Reconciled Balance Sheet and P&L accounts at month-end relating to Direct Labor performance and Distressed Inventory. Supported 14 onsite capital projects by working closely with cross-functional teams to manage deadlines and CIP capitalization. Designed automated system using Excel Macros for capturing signing rights data in order to improve usability and compliance.Rotation 4: Abbott Diagnostics Division, Hematology. Santa Clara, CaliforniaSupported Indirect Manufacturing, including R&D, QA, and Production Administration. Provided FP&A support to the related budget managers, including monthly Actuals compared to Plan and a rolling Latest Best Estimate (LBE) budget for the remainder of the year. Additionally, supported a large-scale outsourcing project with over $10M in expenditures by providing monthly financials to the management team and developed the tools necessary to do so.